Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

703 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer.
Zhu X, Daffada AA, Chan CM, Dowsett M. Zhu X, et al. Among authors: dowsett m. Int J Cancer. 1997 Aug 7;72(4):574-80. doi: 10.1002/(sici)1097-0215(19970807)72:4<574::aid-ijc4>;2-n. Int J Cancer. 1997. PMID: 9259393
Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptor.
Davies JH, Shearer RJ, Rowlands MG, Poon GK, Houghton J, Jarman M, Dowsett M. Davies JH, et al. Among authors: dowsett m. J Enzyme Inhib. 1992;6(2):141-7. doi: 10.3109/14756369209040745. J Enzyme Inhib. 1992. PMID: 1284430
A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.
Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratton MR. Wooster R, et al. Among authors: dowsett m. Nat Genet. 1992 Oct;2(2):132-4. doi: 10.1038/ng1092-132. Nat Genet. 1992. PMID: 1303262
Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines.
Ryde CM, Nicholls JE, Dowsett M. Ryde CM, et al. Among authors: dowsett m. Cancer Res. 1992 Mar 15;52(6):1411-5. Cancer Res. 1992. PMID: 1311630
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.
Butta A, MacLennan K, Flanders KC, Sacks NP, Smith I, McKinna A, Dowsett M, Wakefield LM, Sporn MB, Baum M, et al. Butta A, et al. Among authors: dowsett m. Cancer Res. 1992 Aug 1;52(15):4261-4. Cancer Res. 1992. PMID: 1322240
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
Dowsett M, Stein RC, Coombes RC. Dowsett M, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):155-9. doi: 10.1016/0960-0760(92)90201-s. J Steroid Biochem Mol Biol. 1992. PMID: 1388047 Review.
The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients.
Jones AL, MacNeill F, Jacobs S, Lonning PE, Dowsett M, Powles TJ. Jones AL, et al. Among authors: dowsett m. Eur J Cancer. 1992;28A(10):1712-6. doi: 10.1016/0959-8049(92)90074-c. Eur J Cancer. 1992. PMID: 1389491
4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer.
Coombes RC, Hughes SW, Dowsett M. Coombes RC, et al. Among authors: dowsett m. Eur J Cancer. 1992;28A(12):1941-5. doi: 10.1016/0959-8049(92)90232-q. Eur J Cancer. 1992. PMID: 1419285 Clinical Trial.
The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.
MacNeill FA, Jones AL, Jacobs S, L√łnning PE, Powles TJ, Dowsett M. MacNeill FA, et al. Among authors: dowsett m. Br J Cancer. 1992 Oct;66(4):692-7. doi: 10.1038/bjc.1992.339. Br J Cancer. 1992. PMID: 1419608 Free PMC article.
Towards a molecular basis for tamoxifen resistance in breast cancer.
Johnston SR, Dowsett M, Smith IE. Johnston SR, et al. Among authors: dowsett m. Ann Oncol. 1992 Jul;3(7):503-11. doi: 10.1093/oxfordjournals.annonc.a058251. Ann Oncol. 1992. PMID: 1498070 Review.
703 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page